Bussiness7 months ago
NeuroSense Announces First Quarter 2024 Business Update
CAMBRIDGE, Mass., May 2, 2024 /PRNewswire/ — NeuroSense Therapeutics Ltd. (Nasdaq: NRSN) (“NeuroSense”), a company developing novel treatments for severe neurodegenerative diseases, today provides a business update....
